Detalhe da pesquisa
1.
Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cells.
Mol Carcinog
; 63(2): 209-223, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37818798
2.
Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer.
Int J Mol Sci
; 22(22)2021 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830174